Your browser doesn't support javascript.
loading
Rifaximin-α reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial.
Patel, Vishal C; Lee, Sunjae; McPhail, Mark J W; Da Silva, Kevin; Guilly, Susie; Zamalloa, Ane; Witherden, Elizabeth; Støy, Sidsel; Manakkat Vijay, Godhev Kumar; Pons, Nicolas; Galleron, Nathalie; Huang, Xaiohong; Gencer, Selin; Coen, Muireann; Tranah, Thomas Henry; Wendon, Julia Alexis; Bruce, Kenneth D; Le Chatelier, Emmanuelle; Ehrlich, Stanislav Dusko; Edwards, Lindsey Ann; Shoaie, Saeed; Shawcross, Debbie Lindsay.
Affiliation
  • Patel VC; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, Denmark Hill, London, SE5 9RS, UK; Institute of Liver Studies, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, 125 Coldharbour Lane, London SE5 9NU, UK; The Roger Will
  • Lee S; Centre for Host-Microbiome Interactions, Dental Institute, King's College London, UK; Science for Life Laboratory, KTH - Royal Institute of Technology, 171 21, Stockholm, Sweden; School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, 61005, Republic of Korea.
  • McPhail MJW; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, Denmark Hill, London, SE5 9RS, UK; Institute of Liver Studies, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, 125 Coldharbour Lane, London SE5 9NU, UK; Imperial Colle
  • Da Silva K; University Paris-Saclay, INRAE, MetaGenoPolis, Jouy-en-Josas, 78350, France.
  • Guilly S; University Paris-Saclay, INRAE, MetaGenoPolis, Jouy-en-Josas, 78350, France.
  • Zamalloa A; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, Denmark Hill, London, SE5 9RS, UK.
  • Witherden E; Centre for Host-Microbiome Interactions, Dental Institute, King's College London, UK.
  • Støy S; Aarhus University Hospital, Department of Hepatology and Gastroenterology, Aarhus, Denmark.
  • Manakkat Vijay GK; Institute of Liver Studies, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, 125 Coldharbour Lane, London SE5 9NU, UK.
  • Pons N; University Paris-Saclay, INRAE, MetaGenoPolis, Jouy-en-Josas, 78350, France.
  • Galleron N; University Paris-Saclay, INRAE, MetaGenoPolis, Jouy-en-Josas, 78350, France.
  • Huang X; Institute of Liver Studies, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, 125 Coldharbour Lane, London SE5 9NU, UK.
  • Gencer S; Imperial College London, Biomolecular Medicine, Division of Computational and Systems Medicine, Department of Surgery and Cancer, London, UK.
  • Coen M; Imperial College London, Biomolecular Medicine, Division of Computational and Systems Medicine, Department of Surgery and Cancer, London, UK.
  • Tranah TH; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, Denmark Hill, London, SE5 9RS, UK; Institute of Liver Studies, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, 125 Coldharbour Lane, London SE5 9NU, UK.
  • Wendon JA; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, Denmark Hill, London, SE5 9RS, UK; Institute of Liver Studies, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, 125 Coldharbour Lane, London SE5 9NU, UK.
  • Bruce KD; King's College London, Institute of Pharmaceutical Science, 5th Floor Franklin-Wilkins Building, London, UK.
  • Le Chatelier E; University Paris-Saclay, INRAE, MetaGenoPolis, Jouy-en-Josas, 78350, France.
  • Ehrlich SD; University Paris-Saclay, INRAE, MetaGenoPolis, Jouy-en-Josas, 78350, France.
  • Edwards LA; Institute of Liver Studies, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, 125 Coldharbour Lane, London SE5 9NU, UK.
  • Shoaie S; Centre for Host-Microbiome Interactions, Dental Institute, King's College London, UK; Science for Life Laboratory, KTH - Royal Institute of Technology, 171 21, Stockholm, Sweden.
  • Shawcross DL; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, Denmark Hill, London, SE5 9RS, UK; Institute of Liver Studies, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, 125 Coldharbour Lane, London SE5 9NU, UK. Electronic add
J Hepatol ; 76(2): 332-342, 2022 02.
Article in En | MEDLINE | ID: mdl-34571050
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatic Encephalopathy / Rifaximin / Inflammation / Liver Cirrhosis / Mucins Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatic Encephalopathy / Rifaximin / Inflammation / Liver Cirrhosis / Mucins Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2022 Document type: Article Country of publication: